Published in BMC Infect Dis on March 30, 2006
Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med (2008) 9.49
Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals. Am J Respir Crit Care Med (2009) 2.80
Dynamic relationship between IFN-gamma and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol (2007) 2.40
Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med (2007) 2.36
Sensitivity of a whole-blood interferon-gamma assay among patients with pulmonary tuberculosis and variations in T-cell responses during anti-tuberculosis treatment. Infection (2007) 1.79
Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report. J Occup Med Toxicol (2006) 1.76
Short-term reproducibility of a commercial interferon gamma release assay. Clin Vaccine Immunol (2009) 1.67
Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia. BMC Infect Dis (2007) 1.48
Using ELISPOT to expose false positive skin test conversion in tuberculosis contacts. PLoS One (2007) 1.45
Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study. Respir Res (2007) 1.45
Utility of interferon-gamma ELISPOT assay responses in highly tuberculosis-exposed patients with advanced HIV infection in South Africa. BMC Infect Dis (2007) 1.31
Quantitative T-cell interferon-gamma responses to Mycobacterium tuberculosis-specific antigens in active and latent tuberculosis. Eur J Clin Microbiol Infect Dis (2008) 1.30
T-SPOT.TB responses during treatment of pulmonary tuberculosis. BMC Infect Dis (2009) 1.27
The impact of HIV infection and CD4 cell count on the performance of an interferon gamma release assay in patients with pulmonary tuberculosis. PLoS One (2009) 1.24
Enhanced diagnosis of HIV-1-associated tuberculosis by relating T-SPOT.TB and CD4 counts. Eur Respir J (2010) 1.17
Superoxide dismutase A antigens derived from molecular analysis of sarcoidosis granulomas elicit systemic Th-1 immune responses. Respir Res (2008) 1.14
IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy. BMC Infect Dis (2011) 1.12
Serial interferon-gamma release assays during treatment of active tuberculosis in young adults. BMC Infect Dis (2010) 1.11
New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response. BMC Infect Dis (2009) 1.05
In vivo and in vitro effects of antituberculosis treatment on mycobacterial interferon-gamma T cell response. PLoS One (2009) 1.03
Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study. BMC Infect Dis (2008) 1.03
Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis cases. PLoS One (2010) 1.00
Reversion and conversion of Mycobacterium tuberculosis IFN-gamma ELISpot results during anti-tuberculous treatment in HIV-infected children. BMC Infect Dis (2010) 0.93
Current issues on molecular and immunological diagnosis of tuberculosis. Yonsei Med J (2007) 0.89
Prospective monitoring reveals dynamic levels of T cell immunity to Mycobacterium tuberculosis in HIV infected individuals. PLoS One (2012) 0.85
Mycobacterium tuberculosis specific CD8(+) T cells rapidly decline with antituberculosis treatment. PLoS One (2013) 0.85
Pairing QuantiFERON gold in-tube with opt-out HIV testing in a tuberculosis contact investigation in the Southeastern United States. AIDS Patient Care STDS (2010) 0.84
Antigen-specific interferon-gamma responses and innate cytokine balance in TB-IRIS. PLoS One (2014) 0.81
Identification of a human immunodominant T-cell epitope of mycobacterium tuberculosis antigen PPE44. BMC Microbiol (2011) 0.80
QuantiFERON-TB Gold In-Tube test conversions and reversions among tuberculosis patients and their household contacts in Addis Ababa: a one year follow-up study. BMC Infect Dis (2014) 0.79
Kinetics of T-cell-based assays on cerebrospinal fluid and peripheral blood mononuclear cells in patients with tuberculous meningitis. Korean J Intern Med (2014) 0.78
T cell monitoring of chemotherapy in experimental rat tuberculosis. Antimicrob Agents Chemother (2011) 0.77
Levels of interferon-gamma increase after treatment for latent tuberculosis infection in a high-transmission setting. Pulm Med (2012) 0.76
QuantiFERON-TB Gold Assay on Plasma for Confirmation of Presumed Tuberculosis-Related Uveitis. J Clin Microbiol (2016) 0.75
Use of the QuantiFERON-TB Gold In-Tube Test in the Diagnosis and Monitoring of Treatment Efficacy in Active Pulmonary Tuberculosis. Int J Environ Res Public Health (2017) 0.75
Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis. Tuberculosis (Edinb) (2015) 0.75
Diagnostic Significance of Mycobacterium tuberculosis T-cell Assays for Active Tuberculosis. Chin Med J (Engl) (2017) 0.75
Effect of chemotherapy on whole-blood cytokine responses to Mycobacterium tuberculosis antigens in a small cohort of patients with pulmonary tuberculosis. Clin Vaccine Immunol (2011) 0.75
Qualitative and quantitative results of interferon-γ release assays for monitoring the response to anti-tuberculosis treatment. Korean J Intern Med (2016) 0.75
Decreased expression of perforin in CD8(+) T lymphocytes in patients with Mycobacterium tuberculosis infection and its potential value as a marker for efficacy of treatment. J Thorac Dis (2017) 0.75
Differential Recognition of Mtb-specific Epitopes as a Function of Tuberculosis Disease History. Am J Respir Crit Care Med (2017) 0.75
Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA (1995) 15.26
Rapid effector function in CD8+ memory T cells. J Exp Med (1997) 6.36
Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA (2005) 5.39
Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis (2004) 4.26
Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol (2001) 3.79
Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis (2004) 2.62
Evolution of epitope-specific memory CD4(+) T cells after clearance of hepatitis C virus. J Immunol (2002) 2.13
Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms. J Immunol (2004) 2.08
Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model. Clin Infect Dis (2004) 1.71
Enzyme-linked immunospot assay responses to early secretory antigenic target 6, culture filtrate protein 10, and purified protein derivative among children with tuberculosis: implications for diagnosis and monitoring of therapy. Clin Infect Dis (2005) 1.69
Global epidemiology of tuberculosis. Clin Chest Med (2005) 1.59
Interferon-gamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment. Int J Tuberc Lung Dis (2005) 1.46
Long-lived immune response to early secretory antigenic target 6 in individuals who had recovered from tuberculosis. Clin Infect Dis (2001) 1.31
Immune responses to mycobacterial antigens in the Gambian population: implications for vaccines and immunodiagnostic test design. Infect Immun (2004) 1.21
Design and implementation of relational databases relevant to the diverse needs of a tuberculosis case contact study in the Gambia. Int J Tuberc Lung Dis (2004) 1.02
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet (2013) 14.06
Role of flies and provision of latrines in trachoma control: cluster-randomised controlled trial. Lancet (2004) 3.69
Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J Infect Dis (2008) 3.15
Effectiveness of an early supplementation scheme of high-dose vitamin A versus standard WHO protocol in Gambian mothers and infants: a randomised controlled trial. Lancet (2007) 3.01
Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum. PLoS Med (2008) 3.01
Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers. Clin Infect Dis (2006) 2.96
A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat Med (2004) 2.93
Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans. N Engl J Med (2011) 2.72
The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study. Clin Infect Dis (2012) 2.70
Large-scale evaluation of enzyme-linked immunospot assay and skin test for diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in The Gambia. Clin Infect Dis (2004) 2.62
Identifying recent adaptations in large-scale genomic data. Cell (2013) 2.57
Pneumococcal vaccination in developing countries. Lancet (2006) 2.45
Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection. PLoS Med (2007) 2.36
How access to health care relates to under-five mortality in sub-Saharan Africa: systematic review. Trop Med Int Health (2010) 2.27
Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease. Eur J Immunol (2009) 2.16
Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants: a longitudinal study. Clin Infect Dis (2008) 2.14
Recognition of stage-specific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis. Clin Vaccine Immunol (2006) 1.99
Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination. J Immunol (2002) 1.98
Intracellular lipophilic inclusions of mycobacteria in vitro and in sputum. Microbiology (2002) 1.97
Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants. Sci Transl Med (2011) 1.94
Mature CD8(+) T lymphocyte response to viral infection during fetal life. J Clin Invest (2003) 1.85
Social contact patterns in Vietnam and implications for the control of infectious diseases. PLoS One (2011) 1.83
Access to health care and mortality of children under 5 years of age in the Gambia: a case-control study. Bull World Health Organ (2009) 1.81
Incidence of tuberculosis and the predictive value of ELISPOT and Mantoux tests in Gambian case contacts. PLoS One (2008) 1.79
Streptococcus suis, an important cause of adult bacterial meningitis in northern Vietnam. PLoS One (2009) 1.79
Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis. PLoS One (2011) 1.73
Bacteraemia in patients admitted to an urban hospital in West Africa. BMC Infect Dis (2007) 1.73
A decline in the incidence of invasive non-typhoidal Salmonella infection in The Gambia temporally associated with a decline in malaria infection. PLoS One (2010) 1.72
Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model. Clin Infect Dis (2004) 1.71
Effect of micronutrient sprinkles on reducing anemia: a cluster-randomized effectiveness trial. Arch Pediatr Adolesc Med (2012) 1.68
Immunogenicity of novel DosR regulon-encoded candidate antigens of Mycobacterium tuberculosis in three high-burden populations in Africa. Clin Vaccine Immunol (2009) 1.67
The epidemiology of interpandemic and pandemic influenza in Vietnam, 2007-2010: the Ha Nam household cohort study I. Am J Epidemiol (2012) 1.67
Serotype and antimicrobial susceptibility patterns of isolates of Streptococcus pneumoniae causing invasive disease in The Gambia 1996-2003. Trop Med Int Health (2006) 1.61
Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis. Pediatrics (2006) 1.56
Mycobacterium africanum elicits an attenuated T cell response to early secreted antigenic target, 6 kDa, in patients with tuberculosis and their household contacts. J Infect Dis (2006) 1.56
Risk factors for pulmonary tuberculosis: a clinic-based case control study in The Gambia. BMC Public Health (2006) 1.55
Effects of community-wide vaccination with PCV-7 on pneumococcal nasopharyngeal carriage in the Gambia: a cluster-randomized trial. PLoS Med (2011) 1.54
Transmission of Streptococcus pneumoniae in rural Gambian villages: a longitudinal study. Clin Infect Dis (2010) 1.52
Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings. Pediatr Infect Dis J (2009) 1.52
Common variants at 11p13 are associated with susceptibility to tuberculosis. Nat Genet (2012) 1.52
Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia. BMC Infect Dis (2007) 1.48
The long-term natural history of trachomatous trichiasis in the Gambia. Invest Ophthalmol Vis Sci (2006) 1.46
Polyfunctional CD4(+) and CD8(+) T cell responses to tuberculosis antigens in HIV-1-infected patients before and after anti-retroviral treatment. J Immunol (2010) 1.45
Using ELISPOT to expose false positive skin test conversion in tuberculosis contacts. PLoS One (2007) 1.45
Infection with Helicobacter pylori is associated with protection against tuberculosis. PLoS One (2010) 1.45
Molecular epidemiology of pneumococci obtained from Gambian children aged 2-29 months with invasive pneumococcal disease during a trial of a 9-valent pneumococcal conjugate vaccine. BMC Infect Dis (2008) 1.43
Vitamin D receptor polymorphisms and susceptibility to tuberculosis in West Africa: a case-control and family study. J Infect Dis (2004) 1.43
Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1), and susceptibility to tuberculosis. J Infect Dis (2002) 1.42
Use of spoligotyping and large sequence polymorphisms to study the population structure of the Mycobacterium tuberculosis complex in a cohort study of consecutive smear-positive tuberculosis cases in The Gambia. J Clin Microbiol (2009) 1.41